Organon tripled sales of the bleeding-control system from 2022 to 2024 and is on track to grow sales again this year.

CLEVELAND, Ohio (June 4, 2025)—Insulin resistance is becoming more common because of a combination of lifestyle factors, genetics, and medical conditions. A lot of those same risk factors play a role ...

Please provide your email address to receive an email when new articles are posted on . Abnormal uterine bleeding incidence had no significant change in the pre-pandemic period vs. the post-vaccine ...

Endometrial cancer, the most common uterine cancer, often begins with subtle symptoms like abnormal bleeding, which can be ...

One common culprit: spending a bit too long in sweaty clothing post-workout, says Dr. Birmingham. New exposures to soaps, ...

Please provide your email address to receive an email when new articles are posted on . Two-thirds of women of child-bearing age who began taking anticoagulants for acute venous thromboembolism had ...

Organon is the latest to join the list, as it has entered into an agreement to sell its Jada System to Laborie Medical ...

A new review article illuminates why physicians should keep coagulation disorders in mind when evaluating patients with heavy abnormal uterine bleeding. Physicians treating patients with heavy ...

Endometrial polyps are benign overgrowths of the uterine lining that frequently present with abnormal uterine bleeding (AUB) and may contribute to infertility through impaired endometrial receptivity.

The acquisition expands Laborie's obstetrics portfolio and demonstrates the company's commitment to delivering innovative, proven solutions to physicians and patients globally.

Early diagnosis of uterine cancer is known to improve a patient’s chances for survival, but previous research has found that Black patients are less likely to receive early diagnoses than people of ...